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PEMBENTUKAN VEKTOR UNTUK PENGEKSPRESSAN LAMPAU HORMON 
PERTUMBUHAN MANUSIA REKOMBINAN DI DALAM Bacillus megaterium 
 
ABSTRAK 
 
 Bagi mengekspreskan gen hGH di dalam Bacillus megaterium, 3 konstrak 
telah direka.  Konstrak-konstrak ini dinamakan sebagai Construct 1 (M7hGH), 
Construct 2 (R2L4sphGH) dan Construct 3 (spBsubhGH).  Construct 1 direka 
dengan memasukkan gen pengawalatur (kodon penamat, tapak perlekatan ribosom, 
jujukan TAACA dan kodon pemula) yang akan diekspreskan di dalam sel.  Manakala 
Construct 2 telah dicipta untuk diekpreskan di luar sel yang mana mengandungi 
isyarat peptida daripada Bacillus brevis dan gen.  Bagi Konstrak 3, isyarat peptida 
daripada Bacillus subtilis CU1065 digunakan untuk pengekspresan di luar sel, tetapi 
gen pengawalatur (kodon penamat, tapak perlekatan ribosom dan kodon pemula 
antara protein xylA dengan hGH) telah disingkirkan untuk menghasilkan protein 
gabungan antara xylA dan gen hGH.  Walaubagaimanapun, tiada pengekspresan 
diperolehi daripada Construct 1 dan Construct 2, mungkin berikutan dengan 
ketidakhadiran penggunaan kodon yang sesuai.  Gen hGH sintetik mengandungi 10 
kodon arginina (AGA) (4.8%) yang frekuensinya lebih tinggi daripada 1.7% AGA dan 
0.9% AGG yang dianggarkan dalam E. coli.  Contruct 3 menghasilkan ~20 kDa 
protein yang tidak dapat dikenalpasti maka, analisis lanjutan ke atas protein tersebut 
diperlukan.  Untuk menentukan kestabilan plasmid, purata peratusan sel yang 
membawa plasmid telah dihitung ke atas ketiga-tiga Konstrak.  Bagi Konstrak 1 
(M7hGH), kadar peratusan pengurangan sel yang membawa plasmid adalah 10% 
bagi setiap generasi, Konstrak 2 (R2L4sphGH) adalah 5% bagi setiap generasi, dan 
4.8% bagi Konstrak 3 (spBsubhGH).  
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CONSTRUCTION OF VECTORS FOR THE OVEREXPRESSION OF 
RECOMBINANT HUMAN GROWTH HORMONE IN Bacillus megaterium 
 
ABSTRACT 
 
In order to express the hGH gene in Bacillus megaterium, 3 constructs were 
designed. The constructs were named as Construct 1 (M7hGH), Construct 2 
(R2L4sphGH) and Construct 3 (spBsubhGH).  Construct 1 was designed with 
regulatory features [stop codon, ribosome binding site (RBS), TAACA sequence and 
start codon] meant for intracellular expression. Construct 2, was created to express 
human growth hormone (hGH) extracellularly by using the signal peptide from 
Bacillus brevis.  For Construct 3, the signal peptide from B. subtilis CU1065 was used 
to express hGH extracellularly but the regulatory gene [stop codon, ribosome binding 
site (RBS) and start codon between xylA protein and hGH] was excluded to create a 
fusion protein combining xylA and the hGH gene.  However, no expressions were 
obtained from Construct 1 and 2 probably due to the presence of unfavourable 
codons.  The synthetic hGH gene contains 10 arginine codons (AGA) (4.8%) in which 
the frequency is much higher than the 1.7% AGA and 0.9% AGG estimated for E. 
coli.  Construct 3 yielded an unidentified ~20 kDa protein and further analysis is 
required to identify the protein.  The average percentage of cells carrying plasmid 
was calculated among these 3 constructs in order to determine the plasmid stability 
For Construct 1 (M7hGH), the average rate of reduction of cells that carry plasmid is 
10% for each generation, Construct 2 (R2L4sphGH) is 5% for each generation and 
Construct 3 (spBsubhGH) is 4.8% for each generation.  
   
 1
INTRODUCTION 
1.0 Introduction 
 Growth hormone (GH) plays an important role in metabolism, protein 
synthesis and cell proliferation (Kostyo and Isaksson, 1977).  Human growth 
hormone (hGH), somatotropin, is a protein consisting of 191 amino acids protein with 
a molecular weight of ~22,000 Da and contains two disulfide bonds.  This hormone is 
essential for linear growth and its application in the treatment of hypopituitary 
dwarfism is well established (Raben, 1958; Goodman et al., 1968).  Growth hormone 
may also be effective in the treatment of other disorders including bone fractures, 
burns and bleeding ulcers (Singh et al., 1998).  A number of strategies have been 
employed for its expression (Goeddel et al., 1979a; Hsiung et al., 1989).  hGH is a 
non-glycosylated protein and hence a prokaryotic expression system is preferred.  
hGH expression in culture media (Hsiung et al., 1989), inclusion bodies (Schoner et 
al., 1985) and periplasmic space (Chang et al., 1987; Ghorpade and Garg, 1993) has 
been documented.   
 Among Gram-positive bacteria, Bacillus subtilis is genetically the most 
thoroughly studied organism.  However, other Bacillus species are of great 
biotechnological interest, since they produce a variety of industrially important 
enzymes, such as proteases and amylases and also vitamins (Priest, 1977).  For the 
production of enzymes on an industrial scale, on the other hand, different species of 
the genus Bacillus are more important such as B. amyloliquefaciens as a source of α-
amylase, B. licheniformis as a producer of alkaline protease and B. megaterium for 
glucose dehydrogenase (Heilmann et al., 1988), and mutarotase (Rygus and Hillen, 
1991).   
 Recently, the construction of a vector for constitutive expression of the 
homologous glucose dehydrogenase and the heterologous chloramphenicol 
acetyltransferase in B. megaterium has been reported (Meinhardt et al., 1989).  
Besides that, there was no indication of proteolytic instability of the products in B. 
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megaterium (Rygus and Hillen, 1991).  The apparent stability of the products 
expressed and the plasmids encoding these genes motivated us to construct a 
heterologous regulated expression for B. megaterium.   
 This thesis describes the construction of plasmid encoding the regulated 
expression of the heterologous human growth hormone (hGH) gene by using Pichia 
pastoris codon preference at high levels in B. megaterium.  The regulatory elements 
used for the construction have been derived from the B. megaterium-encoded operon 
for xylose utilization (Rygus et al., 1991). 
 
1.1 Research objectives 
Due to the importance of rhGH to humanity and potential demand in 
biopharmaceutical market, the application of genetic engineering was widely 
used to produce this protein in genetically selected and modified 
microorganisms.  In recent years, Bacilli have become very important 
experimental models in both microbiological and genetic research.       
Therefore, in this research, the cloning and expression of rhGH in B. 
megaterium expression system was carried out.  The objectives of this 
research are: 
(1) To express the recombinant hGH protein in B. megaterium ; 
(2) To express synthetic hGH gene extracellularly by adding the 
signal peptide sequence. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.0 Literature Review 
2.1 Human Growth Hormone 
2.1.1 Historical Background 
 Growth hormone (GH) has been in the forefront of endocrine research for 
almost one hundred years.  Early research studied by Bell (1917), Evans and Long 
(1921) and Smith (1927 & 1930) found out how hypophysectomy affected the body 
size of the rat, the frog, and the dog.  They also found that in the young animal, 
hypophysectomy stunted growth, and in the mature animal it caused weight loss and 
visceral atrophy.  Exogenous administration of pituitary extracts reversed these 
effects.  From these observations emerged the concept of a pituitary growth hormone 
or somatotropin. 
 Li and co-workers isolated GH from bovine pituitary glands in 1945 (Li et al., 
1945).  Subsequent work by Li, as well as by Wilhelmi and others in 1948 (Wilhelmi 
et al., 1948) established procedures for isolating human GH (hGH) in what was 
considered to be homogenous from by the standards of the 1950s, e.g. ion-exchange 
resin and cellulose column chromatography, paper electrophoresis, and 
sedimentation analysis (Smith et al., 1949).  It was recognized that the hormone not 
only stimulated growth of the skeletal and soft tissues, but also influenced protein, 
carbohydrate, and fat metabolism.    
    For the past 25 years, human growth hormone (hGH) has been used for 
treatment of certain disease states associated with short stature, especially growth 
hormone deficiency (Rabens, 1958).  Unlike other peptide hormones such as insulin, 
the homologous hormone from other species is inactive in man (Bergenstal and 
Lipset, 1960).  Therefore the only source of growth hormone has been human 
pituitary gland obtained at necropsy.  In the United States the collection of pituitary 
glands, purification of growth hormone, and distribution of hGH to research-workers 
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for use in patients has been centralized by the National Pituitary agency under the 
auspices of the National Institutes of Health.  This program has yielded much useful 
research on growth hormone therapy and hundreds of patients have benefited. 
Techniques in molecular biology have led to the ability to isolate the hGH 
mRNA and to make partly synthesized hGH gene.  In 1979, hGH was directly 
expressed in Escherichia coli using pBR322 as a cloning vector (Goeddel et al., 
1979a).  This biosynthetic hGH has exactly the same amino acid sequence as 
pituitary hGH, with the additional of a methionyl residue on the N-terminal end.  This 
development provides an essentially unlimited supply of hGH for research and 
treatment.  Previous work has shown that this synthetic methionyl human growth 
hormone (met-hGH) is biologically active in animals without detectable adverse side-
effects (Olson et al., 1981). 
Human growth hormone was first used to treat stunted growth in children.  
Clinically, deficiencies in growth hormone or receptor defects manifest as growth 
retardation or dwarfism.  The effect of excessive secretion of growth hormone is also 
very dependent on the age of onset and is seen as two distinctive disorders such as 
giantism that begin in young children and acromegaly that occur in adults.  Later, it 
was used in people with HIV disease to treatment the gauntness of AIDS-related 
wasting and, more recently, the fat accumulations associated with lipodystrophy.  
HGH may also play a role in immune reconstitution.  Lately, the application of hGH 
was approved by FDA for the treatment of AIDS-related wasting syndrome (Roehr, 
2003).   
  
2.1.2 Structure of the hGH Genes 
 Human growth hormone (hGH) is a single chain polypeptide of 191 amino 
acids with two loops formed by disulfide bridges (Figure 2.1).  The molecule is 
predominantly α-helical in secondary structure (Chawla et al., 1983). 
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Figure 2.1 Covalent structure of hGH.  hGH has two d  bonds between residues 53-165 
and 182-189. (Picture adapted from Chaw 983) isulphide
la et al., 1
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In humans, the long arm of chromosome 17 (q22-24) contains cluster of five GH-
related genes.  A report has been made by Martial et al. and by Roskam & Rougeon 
in 1979 where they constructed recombinant DNA copies of pre-hGH mRNA from 
human pituitary glands.  The sequence was found to be 94% homologous with the 
sequence of human chorionic somatomammotropin (hCS).  Fiddest et al. (1979) 
found that there were two nonallelic copies of hGH genes and at least three copies of 
hCS genes in each hGH and hCS gene cluster.  These include the normal pituitary 
hGH or hGH-N gene (DeNoto et al., 1981; Seeburg, 1982) in the somatotroph cell 
(Wood, 2001), the nonallelic variant hGH or hGH-V gene (Seeburg, 1982) produced 
by placenta during pregnancy (Wood, 2001), an hCS gene whose sequence differs 
slightly from that of the major component of hCS mRNA (Seeburg, 1982) and another 
hCS gene (Chawla et al., 1983).  However, the exact number and linear array of hGH 
and hCS genes are not known (Chawla et al., 1983).  This family of gene is shown in 
Figure 2.2 while Table 2.1 lists the molecular forms of pituitary human growth 
hormone. 
 Figure 2.3 shows the theoretical representation of the hGH gene and the 
mRNA from it.  There are five exons or coding sequence designated I-V, which are 
separated by four introns or interverning sequences designated A-D.  The positions 
and lengths of the four introns are identical in the hGH-N, hGH-V and hCS genes 
(Chawla et al., 1983).  Exon I contains some 5’ untranslated nucleotides, trinucleotide 
codons -26 to -24 of the pre-hGH signal peptide, and the first nucleotide of codon -
23.  The second exon codes for the remainder of the signal peptide and amino acids 
1 to 31 of hGH.  Exons III, IV, and V code for amino acids 32 to 71, 71 to 126 and 
127 to 191, respectively.  Introns A, B, C and D contain 256, 209, 93 and 253 base 
pairs.  Each intron begin with a GH dinucleotide and ends with an AG.  Coding 
sequences are spliced together at these junctions during the post-transcriptional  
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Figure 2.2 Map of human chromosome 17.  The dark and the light bands are 
given numbers outward from the centromere to facilitate identification.  
The GH gene family is located on the long arm, designated Q, 
somewhere within the region of bands 22-24.  There are two identical 
copies of hGH-N gene, one copy of the hGH-V gene, and an unknown 
number of copies of three different hCS genes.  (Picture adapted from 
Chawla et al., 1983) 
 
 
 
              P 
                         Q 
Growth Hormone Family 
2 copies of hGH-N 
1 copy of hGH-V 
3 different of hCS genes 
   (unknown number of copies) 
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Table 2.1              Effects of hGH (Table was adapted from Chawla et al., 1983) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Metabolic Stimulates amino acid transport 
Stimulates protein synthesis in most cell types 
  Stimulates DNA/RNA synthesis in most cell types 
  Stimulates polyamine synthesis 
  Inhibits insulin action on glucose metabolism 
 
Physiologic Increases renal blood flow, glomerular filtration rate, and
reabsorption of PO4 
 Increases basal metabolic rate 
 Stimulates new bone formation 
 Stimulates erythropoiesis 
 Expands extracellular fluid space 
 
Anatomic Accelerates linear growth 
 Reduces adipose mass and enlarges lean body mass (muscle, liv
kidney, heart, pancreas, skeleton, connective tissue)  tubular 
er, 
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Figure 2.3 Theoretical representations of the hGH gene and the mRNA.  The 
hGH gene contains three introns: intron A between amino acids (AA) 
24, intron B between AA 31 and 32, and intron C between AA 71 and 
72.  These are excised out when the gene is transcribed into the 
mRNA for the hormone (Picture adapted from Chawla et al.,1983) 
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processing of mRNA (Chawla et al., 1983).  The hGH-N gene contains an alternate 
splice point [designated B’ in Figure 2.3 preceding the codon for amino acids 47 
(DeNoto et al., 1981; Seeburg, 1982)].  32 to 46 of 22K hGH (Lewis et al., 1980).  As 
suggested by Wallis (1980), the 20K hGH, which lacks amino acids 32 to 46 of 22K 
hGH (Lewis et al., 1980), may arise from splicing of the pre-hGH messenger 
precursor RNA at this point. 
 Human growth hormone binds to specific receptors on cultured human 
lymphocytes; on the plasma membrane fraction of leporine or rodent hepatocytes 
and of leporine mammary glands; and on human, canine, or rodent adipocytes 
(Lesniak et al., 1973; Moore and Jin, 1978; Fagin et al., 1980). 
 Transcription and translation give rise to two forms of hGH in the pituitary.  
The two forms are a 22-kDa form, which accounts for approximately 90% of GH 
produced, and a 20-kDa form resulting from an alternative splice site on exon 3, 
which accounts for 5-10% of hGH production.  The 20-kDa form of hGH lacks a 
sequence of 15 amino acids present at position 32-46 in the 22-kDa molecule and 
has a total of 176 residues compared with the 191 residues in the 22-kDa peptide.  
The bioactivity of 20-kDa hGH is less than that of the 22-kDa form in most of the 
assay systems tested in vitro but the in vivo bioactivity in humans is unknown (Wood, 
2001).  Figure 2.4 shows the mRNA sequence and the amino acids sequence of 
hGH (Roskam and Rougeon, 1979).  
 
2.1.3 hGH synthesis 
 Human growth hormone (hGH) is synthesized in somatotropes, a subclass of 
the pituitary acidophilic cells where somatotropes are the most abundant cells in the 
gland.  The concentration of hGH in the pituitary is 5-15mg/g, which is much higher 
than the microgram per gram quantities of other pituitary hormones (Murray et al., 
1993).  The expression of hGH is restricted to the pituitary and regulated by pituitary 
transcription factor-1 (GHF-1) which binds to the hGH promoter acting in concert with
   
-26 -25 -24 -23 -22 -21 -20 -19 -18 -17 -16 -15 -14 -13 -12 -11 -10 
AUG GCU ACA GGC UCC CGG ACG UCC CUG CUC CUG GCU UUU GGC CUG CUC UGC 
Met Ala Thr Gly Ser Arg Thr Ser Leu Leu Leu Ala Phe Gly Leu Leu Cys 
                 
-9 -8 -7 -6 -5 -4 -3 -2 -1 1 2 3 4 5 6 7 8 
CUG CCC UGG CUU CAA GAG GGC AGU GCC UUC CCA ACU AUA CCA CUA UCU CGT 
Leu Pro Trp Leu Gln Glu Gly Ser Ala Phe Pro Thr Ile Pro Leu Ser Arg 
                 
9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
CUA UUC GAU AAC GCU AUG CUU CGU GCU CAU CGU CUU CAU CAG CUG GCC UUU 
Leu Phe Asp Asn Ala Met Leu Arg Ala His Arg Leu His Gln Leu Ala Phe 
                 
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 
GAC ACC UAC CAG GAG UUU GAA GAA GCC UAU AUC CCA AAG GAA CAG AAG UAU 
Asp Thr Tyr Gln Glu Phe Glu Glu Ala Tyr Ile Pro Lys Glu Gln Lys Tyr 
                 
43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 
UCA UUC CUG CAG AAC CCC CAG ACC UCC CUC UGU UUC UCA GAG UCU AUU CCG 
Ser Phe Leu Gln Asn Pro Gln Thr Ser Leu Cys Phe Ser Glu Ser Ile Pro 
                 
60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 
ACA CCC UCC AAC AGG GAG GAA ACA CAA CAG AAA UCC AAC CUA GAG CUG CUC 
Thr Pro Ser Asn Arg Glu Glu Thr Gln Gln Lys Ser Asn Leu Glu Leu Leu 
                 
77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 
CGC AUC UCC CUG CUG CUC AUC CAG UCG UGG CUG GAG CCC GUG CAG UUC CUC 
Arg Ile Ser Leu Leu Leu Ile Sln Ser Trp Leu Glu Pro Val Gln Phe Leu 
                 
94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 
AGG AGU GUC UUC GCC AAC AGC CUA GUG UAC GGC GCC UCU GAC AGC AAC GUC 
Arg Ser Val Phe Ala Asn Ser Leu Val Tyr Gly Ala Ser Asp Ser Asn Val 
                 
111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 
UAU GAC CUC CUA AAG GAC CUA GAG GAA GGC AUC CAA ACG CUG AUG GGG AGG 
Tyr Asp Leu Leu Lys Asp Leu Glu Glu Gly Ile Gln Thr Leu Met Gly Arg 
                 
128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 
CUG GAA GAU GGC AGC CCC CGG ACU GGG CAG AUC UUC AAG CAG ACC UAC AGC 
Leu Glu Asp Gly Ser Pro Arg Thr Gly Gln Ile Phe Lys Gln Thr Tyr Ser 
                 
145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 
AAG UUC GAC ACA AAC UCA CAC AAC GAU GAC GCA CUA CUC AAG AAC UAC GGG 
Lys Phe Asp Thr Asn Ser His Asn Asp Asp Ala Leu Leu Lys Asn Tyr Gly 
                 
162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 
CUG CUC UAC UGC UUC AGG AAG GAC AUG GAC AAG GUC GAG ACA UUC CUG CGC 
Leu Leu Tyr Cys Phe Arg Lys Asp Met Asp Lys Val Glu Thr Phe Leu Arg 
                 
179 180 181 182 183 184 185 186 187 188 189 190 191     
AUC GUG CAG UGC CGC UCU GUG GAG GGC AGC UGU GGC UUC    
Ile Val Gln Cys Arg Ser Val Glu Gly Ser Cys Gly Phe     
Figure 2.4 The mRNA sequence and the amino acids sequence of hGH.  The numbers above the mRNA  
  sequence represent the location of the amino acids; 1-191 represent mature hGH and -26 to -1  
  represent signal peptide of hGH (Reproduced from Roskam and Rougeon, 1979). 11 
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several other more ubiquitous DNA binding proteins (Miyachi et al., 1993).  The 
secretion of hGH is regulated by growth hormone releasing hormone (GHRH) and 
somatostatin. GHRH controls hGH synthesis by stimulating transcription of hGH 
mRNA while somatostatin determines the timing and amplitude of hGH pulses 
(Miyachi et al., 1993).  The pulsatile GH secretion is influenced by a number of 
neurogenic, metabolic and hormonal factors. 
 
2.1.4 Biochemical and Physiologic Characteristics of hGH 
 Human growth hormone is essential for postnatal growth and for normal 
carbohydrate, lipid, nitrogen and mineral metabolism.  The growth related effects are 
primarily mediated by IGF-I (Insulin-Like Growth Factor-I), a member of the insulin-
like gene family (Javier et al., 1996).  Another closely related peptide found in human 
plasma, IGF-II (Insulin-like Growth Factor-II) has activity similar or identical to what is 
often referred to in the rat as multiplicational-stimulating activity (MSA) (Javier et al., 
1996).  IGF-I and IGF-II both bind to membrane receptors; however, they can be 
differentiated on the basis of specific radioimmunoassay.  IGF-I has 70 amino acids 
and IGF-II has 67.  Plasma level of IGF-II are twice those of IGF-I, but it is IGF-I that 
correlates most directly with growth hormone effects (Javier et al., 1996).  Individuals 
who lack sufficient IGF-I but have IGF-II fail to grow normally (Franchimont and  
Burger, 1975).  
  Table 2.1 summarizes the biologic effects associated with hGH.  The primary 
function of the hormone is to promote proportionate growth of both soft and skeletal 
tissues.  These anabolic effects are at least in part mediated by hGH-dependent 
growth factors called somatomedin (Wilhelmi, 1982). 
 The growth-promoting characteristic of hGH is measured by either (a) the 
weight gain test, in which the increase in body weight of the young 
hypophysectomized rat is monitored during ten daily injections of the hormone, or (b) 
the tibia assay, in which the growth of the proximal epiphysis of the tibia of the young 
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hypophysectomized rat is measured after daily hGH injections.  Other assays 
measure metabolic actions of the hormone on muscle, adipose tissue and mammary 
gland.  The latter organ reveals the lactogenic property of hGH (Rudman, 1981).  
 
2.1.4.1 Carbohydrate metabolism 
 Growth hormone generally antagonizes the effects of insulin.  Hyperglycemia 
after growth hormone administration is the combined result of decreased peripheral 
utilization of glucose and increased hepatic production via gluconeogenesis 
(Franchimont and Burger, 1975).  In the liver, growth hormone increases liver 
glycogen, probably from activation of gluconeogenesis from amino acids.  
Impairment of glycolysis may occur at several steps and the mobilization of fatty 
acids from triacylglycerol stores may also contribute to the inhibition of glycolysis in 
muscle (Franchimont and Burger, 1975).  Prolonged administration of growth 
hormone may result in diabetes mellitus (Franchimont and Burger, 1975). 
 
2.1.4.2 Lipid metabolism 
 Growth hormone promotes the release of free fatty acids and glycerol from 
adipose tissue, increases circulating free fatty acids and causes increased oxidation 
of free fatty acids in the liver.  Under conditions of insulin deficiency as diabetes, 
increased ketogenesis may occur.  These effects and those carbohydrate 
metabolisms probably are not mediated by IGF-I (Franchimont and Burger, 1975). 
 
2.1.4.3 Mineral metabolism 
 Growth hormone promotes a positive calcium, magnesium and phosphate 
balance and causes the retention of Na+, K+ and Cl-.  The first effect probably relates 
to the action of growth hormone in bone, where it promotes growth of long bones at 
the epiphysial plates in growing children and appositional or acral growth in adults.  
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In children, growth hormone also increases formation of cartilage (Franchimont and 
Burger, 1975). 
 
2.1.4.4 Prolactin-like effects 
 Growth hormone binds to lactogenic receptors and thus has many of the 
properties of prolactin, such as stimulation of the mammary glands, lactogenesis 
(Franchimont and Burger, 1975) 
 
2.1.5 Recombinant hGH 
 Since the introduction of recombinant human growth hormone (rhGH), several 
clinical trials have examined the characteristics of growth hormone deficiency (GHD) 
and the effect of growth hormone (GH) replacement therapy in adults with GHD.  
Adults with GHD appear to have muscle weakness that can be improved with rhGH 
therapy (Cuneo et al., 1990; Rutherford et al., 1994; Beshyah et al., 1995; 
Johannsson et al., 1997; Sartorio et al., 1995).  Due of the main cause of the 
decrease in muscle strength is a decrease in muscle mass, which is frequently 
reported in adults with GH deficiency.  Normal quadriceps strength per thigh muscle 
mass, estimated by anthropometry, was reported in a small group (n=6) of patients 
with childhood-onset (Sartorio et al., 1995). 
 Since the successful synthesis of hGH by recombinant DNA technology 
(Goeddel et al., 1979b), hGH therapy in Turner’s syndrome began systematically as 
clinical trials (Takano et al., 1986; Takano et al., 1989; Raiti et al., 1986; Rosenfeld et 
al., 1988). 
 Patients with thermal burns have increased protein catabolism, impaired 
wound healing, depressed immune response and high incidence of sepsis (Wolfe, 
1986 and Batstone et al., 1982).  Decreased bioavailability as well as low circulating 
levels of anabolic hormones (GH, insulin, IGF-1 and testosterone) has been reported 
in major burn injury that correlate with negative nitrogen balance (Jenkins and Ross, 
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1996).  Recombinant human growth hormone (rhGH) therapy in burned patients has 
been reported to reduce protein catabolism, improve donor site healing and decrease 
mortality (Jenkins and Ross, 1996).  Severe protein catabolism, delay in wound 
healing, sepsis and multiorgan dysfunction are major factors influencing morbidity 
and mortality in burns (Jenkins and Ross, 1996). 
 
2.2 Techniques of synthetic gene construction 
2.2.1 Background 
 Within recent years, a great deal of interest has been focused on the cloning 
of DNA sequences coding for biologically and medically important proteins.  Recent 
advances in the chemical synthesis of oligodeoxyribonucleotides have now made it 
possible to chemically synthesize DNA sequences coding for proteins composed of 
well over 100 amino acids (Edge et al., 1981).  The advantages of chemically 
synthesizing such sequences, reside in the greater potential for engineering certain 
desired features into these DNAs.  These may include conveniently placed restriction 
endonuclease sites and transcriptional and translational regulatory signals (Edge et 
al., 1981; Itakura et al., 1977; Crea et al., 1978; Goeddel et al., 1979b) as well as 
codon usage designed to maximize the use of the most abundant species of tRNAs 
for a given organism (Edge et al., 1981 and Ikemura, 1981). 
 Modification of a gene in a controlled fashion is an important tool in the fields 
of molecular genetics and protein engineering.  Small alteration can be obtained by 
either an oligonucleotide-directed “site-specific” mutagenesis or localized random 
mutagenesis of a gene already cloned in a plasmid vector (Gilliam et al., 1979; 
Miyada et al., 1982; Shortle et al., 1980; Botstein and Shortle, 1985).  However, if 
extensive or multiple alterations are required, for example, in the preparation of 
homologous proteins of different species, the oligonucleotide-directed mutagenesis 
would appear to be too cumbersome (Sung et al., 1986).  In this situation, separate 
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synthesis of individual genes would be a more appropriate approach, albeit a 
laborious one (Jay et al., 1984). 
 The assembly of DNA sequences from oligos finds applications in DNA 
synthesis, gene expression and in vitro mutagenesis.  Several publications describe 
the assembly of DNA sequences from oligos by gene assembly techniques (Agarwal 
et al., 1970), in-frame cloning method, solid phase gene assembly, chemical 
assembly of gene PCR-mediated gene assembly and by the FokI method of gene 
synthesis (Mandecki et al., 1988).  Recently, DNA shuffling was introduced as a 
method for in vitro recombination by combinatorial assembly of genes from random 
fragments generated by partial DNaseI digestion (Stemmer, 1994a, b), or from a 
mixture of oligos and random fragments (Crameri and Stemmer, 1995).   
 
2.2.2 Gene assembly techniques  
 There are several approaches for the assembly of synthetic genes.  The 
principal method for assembling DNA duplexes from synthetic oligonucleotides was 
the joining of complementary overlapping complexes with the aid of T4 DNA ligase.  
This method was first elaborated in the late 1960s by Har Gobind Khorana (Agarwal 
et al., 1970).  In this approach, a series of sequentially overlapping oligonucleotides 
were annealed under optimized condition to form a double stranded DNA fragment 
containing nicks on both strands, which were sealed with DNA ligase.  The first 
successful case of this technique was reported by Sekiya et al. (1979) in the 
synthesis of tyrosine suppressor tRNA gene using polynucleotide kinase and 
polynucleotide ligase to join 10 oligonucleotide segments to form the 62-nucleotide-
long DNA fragment.  Later, Smith and coworkers (1982) also reported the synthesis 
of human β-urogastrone gene from 23 oligonucleotides using T4 DNA ligase to ligate 
the phosphorylated oligonucleotides sequentially.  Subsequently, this strategy was 
applied broadly to the synthesis of many genes prior to expression in E. coli, for 
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instance, human immune interferon (Tanaka and Robey, 1983) and human 
interferon-α2 gene (Edge et al., 1981).  
 Rossi et al. (1982) developed an alternative strategy where two sets of two 
long oligonucleotides (about 40 bases length) were constructed of which the 
complementary 3’-ends (about 10 bases) of the oligonucleotides overlapped, thus, 
allowed to anneal.  The two constructs were completed to a full-length double strand 
DNA by a subsequent filling-in reaction in the presence of DNA polymerase l (Klenow 
fragment) with dNTPs.  After polymerization, overhanging ends were generated on 
the double stranded DNA fragment with restriction endonucleases EcoR l and Pst l, 
respectively, prior to cloning into EcoR l-Pst l-digested pXJ001 plasmid. 
 An alternative strategy to synthesize simultaneously two DNA duplexes was 
reported by Sung et al. (1986).  This strategy was called ‘hybrid gene synthesis’, 
which produced both human and mouse epidermal growth factors (hEGF and mEGF) 
simultaneously.  In this approach, four oligonucleotides encoding hEGF and three 
oligonucleotides encoding mEGF were synthesized.  The positive strand encoded 
hEGF while the negative strand encoded mEGF as complementary sequence.  Upon 
annealing, overlapped oligonucleotides containing specific regions of mismatched 
bases were ligated to linearized pUC8 plasmids, yielding heteroduplex plasmids.  
After transformation, each plasmid strand act as a template yielding two plasmid 
progenies bearing two related genes.   
 There was another ‘in vitro’ method of assembling a synthetic gene reported 
by Narang et al. (1986) whereby a mixture of linearized plasmid containing six 
synthetic complementary oligonucleotides was directly transformed into competent 
cells.  They found that 1 out of 100 transformants was positive in colony hybridization 
using one of the synthetic fragment probe (Narang et al., 1986).  This technique is 
simple and not suitable for a large gene synthesis.  Furthermore, the assembly 
efficiency of the host cells is lows, thus, multiple screening test needed to be carried 
out for positive result.      
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2.2.3 In-frame cloning methods 
 Another assembly technique utilizing cloning approach was reported by 
Adams et al. (1988) whereby the HIV-1 tat synthetic gene was generated.  This 
technique involved the synthesis of large oligonucleotides covering one strand of the 
entire desired gene (positive strand) and the utilization of short complementary 
bridging oligonucleotides (negative strand) to direct the assembly of the large DNA 
fragments.  The partially single-stranded intermediate was ligated to the cloning 
vector and transformed directly into the recipient bacterial host where the 
recombinant plasmid was repaired.  This approach exploited the nature of E. coli 
DNA repair mechanisms to ‘fill-in’ breaks or gaps in a partially constructed gene.  
Again, this technique is simple, however, multiple screening tests needed to be 
carried out for positive result. 
 
2.2.4 Solid phase gene assembly 
 With the advent of automated gene synthesis, the use of magnetic beads to 
synthesize larger DNA fragment was established.  This strategy enables the rapid 
and cost-effective preparation of long duplex DNA region (Beattie and Fowler, 1991).  
Hostomsky et al. (1987) reported the construction of cow colostrum trypsin inhibitor 
gene using this technique.  Basically, this approach is comprised of three steps.  In 
the first step, an anchor oligonucleotide was covalently bound to the CNBr-activated 
Sepahcryl S-500 support.  Next, with proper washing after each step, assembly of 
the gene by stepwise hybridization of the phosphorylated oligonucleotides to the 
immobilized complementary sequence was carried out.  In the last step, a linearized 
vector was ligated to the assembled gene.  Finally, the complete gene construct was 
released from the solid support with a restriction enzyme, circularized and used for 
transformation. 
 Hostomsky and coworkers (1987) found a number of advantages in this 
approach.  Most of the enzymes or enzyme systems, including T4 DNA ligase, 
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polynucleotide kinase, restriction endonuclease and splicing extracts, were active in 
Sephacryl S-500 with bound nucleic acids comparable with that of homogenous 
solutions.  This system enabled rapid and efficient change of buffers, as well as 
removal of unbound reaction products via washing steps.  The gene assembly 
process was straight forward and purification step was simple with no need of 
electrophoretic separations up to the stage of harvesting the recombinant clones. 
 
2.2.5 Chemical assembly of gene 
 Extensive studies of chemical reactions in DNA duplexes have made it 
possible to develop a procedure alternative to the enzymatic method for the 
assembly of extended double-stranded DNAs from oligonucleotides using a chemical 
reagent.  Shabarova et al. (1990) reported a total chemical assembly genes using 
condensing agent (cyanogen bromide) for the assembly of 35- to 53-membered 
oligonucleotides to generate a 183 bp gene.  The reaction is complete within several 
minutes at 0oC in buffer.  Shabarova and coworkers (1991) found that this approach 
demonstrated a number of advantages over enzymatic method, which include a high 
reaction rate (1 or 2 min versus 12-14 h with DNA ligase) with the absence of by-
product, higher possibility of introducing various modifications and low cost of the 
reagents as compared with the enzymes.  Nevertheless, to generate a relatively long 
DNA fragment, the utilization of enzyme for joining oligonucleotides together was 
essential (Shabarova et al., 1991). 
 
2.2.6 PCR-mediated gene assembly 
 Jayaraman and Shah (1987) introduced a PCR-mediated gene synthesis 
approach that involved a single-step ligation of overlapping oligonucleotides 
comprising the entire gene followed by PCR amplification of the crude ligation 
mixture, with two outer primers, to generate the full-length gene.  With this method, 
they successfully synthesized several genes, including the horseradish peroxidase 
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gene (Jayaraman et al., 1991).  Jayaraman and Puccini (1992) applied the PCR-
mediated gene synthesis approach to the assembly of oligonucleotides that 
correspond to only one strand of the gene.  In that study, a mixture containing 3 long 
olgonucleotides (>100 bp) corresponding to only one of the strands, short 
oligonucleotides (~20 bp) that were complementary at the junction of the long 
oligonucleotides and two outer primers (~20 bp) was subjected to PCR to generate a 
full-length double-stranded gene. 
 Dillon and Rosen (1990) also developed a rapid method for the construction 
of synthetic gene using the PCR strategy.  Multiple overlapping oligonucleotides were 
used to generate synthetic DNA through several sequential rounds of Klenow-based 
PCR amplification.  In their report, two-step PCR protocol using the thrmostable Taq 
polymerase was carried out to create a synthetic gene for the HIV-2 Rev protein.  
Upon annealing, 4 overlapping oligonucleotides (each 105 nucleotides in length with 
20-25 complementary sites) served as ‘template’ as well as ‘primers’ in the primary 
PCR amplification.  Then, the PCR product was added as template into a mixture 
containing 5’- and 3’-flanking primers for secondary PCR amplification to generate a 
full-length double-stranded gene. 
 Another simple and rapid single-step assembly gene approach involving PCR 
by using a thermostable polymerase for the filling-in reactions of overlapping 
complementary oligonucleotides was reported by Stemmer et al. (1995).  This 
strategy was derived from DNA shuffling (Stemmer, 1994b) independent of DNA 
ligase activity but instead relied on DNA polymerase for longer DNA construction.  In 
this approach, a 1.1 kb DNA fragment containing TEM-1 β-lactamase-encoding gene 
(bla) was assembled in a single-step polymerase chain reaction from a total of 56 
oligonucleotides, each 40 nucleotides in length.  Norazmi and coworkers (1999) 
successfully applied this technique for the cloning of a malarial epitope into 
Mycobacterium smegmatis.  Barnes and Frawley (2003) carried out a comparison 
study between their method and that of Stemmer et al. (1995) and reported that the 
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smearing phenomenon at the first step assembly PCR product could be reduced 
using less amounts of DNA (1 pmole each oligonucleotide in 100 µL reaction) and 
longer extention time (20 minutes) in less PCR cycles (25 cycles).   
 
2.2.7 FokI method of gene synthesis 
 Mandecki and Bolling (1988) developed a fast and simple method for 
synthesis of a gene, or any DNA fragment with a defined sequence.  This method 
was applied to the synthesis of a gene fragment encoding the N-terminal 143 amino 
acid residues of human immunodeficiency virus transmembrane protein.  This 
method is based on the observation that large (approximately 100 bp long) inserts 
can be cloned into plasmid using a technique of oligonucleotide-directed double-
strand break repair.  The procedure involves tramsformation of E. coli with a 
denatured mixture of an insert-carrying oligo and linearized plasmid DNA (Mandecki, 
1986).  The nucleotide sequences are inserted between two FokI restriction nuclease 
sites in one of four pUC-derived plasmids.  Since FokI makes a staggered double-
strand break at a DNA site 9 and 13 nucleotides away from its recognition site, upon 
cleavage of the plasmid DNA with FokI, a restriction fragment is liberated that by 
design contains unique 4-nucleotide-long 5’-protruding ends.  The uniqueness of 
ends permits efficient and directed simultaneous ligation of several restriction 
fragments to form a gene.  This method offers flexibility due to the modular-type 
assembly and does not require any restriction sites within the constructed gene.  The 
sequence error rate is low and just about one error per 4000 bp of DNA cloned 
(Mandecki and Bolling, 1988).  
 
 
2.3  Bacillus megaterium expression system 
2.3.1 General features of Bacillus megaterium 
 Bacillus megaterium has fascinated microbiologist since it was first described 
over 100 years ago.  It is interesting especially because of its physiology, unusual 
   
22 
 
and useful enzymes and products, also the wide range of ecological habitats.  It is 
also capable of sporulation, a simple cell differentiation cycle that serves as a model 
system for understanding gene regulation during temporal and morphological 
development.  Moreover, the source of the significant name “megaterium” was the 
large size of the vegetative cells and spores make it especially amenable to 
morphological analysis (Harwood et al., 1990; Priest, 1989).  
 B. megaterium is able to grow on a wide variety of carbon sources and has, 
thus, been found in many ecological niches, such as waste from meat industry or 
petrochemical effluents.  Also documented has been the degradation of persistent 
insecticides by B. megaterium (Sexana et al., 1987; Selvanayagam and Vijaya, 1989) 
offering potential applications as detoxifying agent.  One of the genetic regulatory 
elements for carbon utilization is the xylose operon.  It has been described by Rygus 
and Hilen (1991). 
 Several B. megaterium proteins are of importance.  A family of P-450 
cytochrome monooxygenases is similar to eukaryotic P-450 playing a role in many 
diseases.  Industrial applications of enzymes excreted by B. megaterium are diverse, 
starting from amylases used in the bread industry to penicillin amidase and steroid 
hydrolases, which is used for generation of new synthetic antibiotics (Vary, 1994).  It 
is the major aerobic producer of vitamin B12 and is one of the organisms involved in 
fish spoilage. 
 During the 1980s, genetic techniques of transduction, plasmid transformation, 
protoplast fusion and transportation became developed enough in B. megaterium to 
apply them to the study of many of its metabolic and developmental functions.  
Moreover, it is increasingly used as a host to produce foreign genes since it has been 
found to express, secrete and process foreign proteins without degradation.   
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2.3.2 Taxonomic position of B. megaterium 
 In order to understand the species, it is necessary to be aware of the great 
diversity in the taxonomy of Bacillus, and within B. megaterium (Claus et al., 1989; 
Priest, 1993).  As can be seen from Figure 2.5, it is within the B. subtilis group, but 
much more distantly related to B. subtilis than B. licheniformis, B. cereus, B. 
anthracis or B. pumilus by 16S rRNA sequence analysis (Ash et al., 1991; Priest, 
1993).   
 Major research strains of B. megaterium include QM B1551, KM, 216, DSM 
319, ATTC 10778 and ATTC 19213.  Strains QM B1551, 216 and IWG3, as well as 
the plasmidless strains PV361, DSM 319 and VT1660 are well-known industrially 
(Vary, 1994). 
 
2.3.3 The cell structure of B. megaterium   
 B. megaterium is one of a few Bacillus strains that have a cell width greater 
than 1 µm (Vary, 1994).  This large size and its ability to take up diaminopimelic acid 
have been exploited in several morphological studies.  It has been used effectively to 
study cell wall synthesis as well as membrane and spore structure as reviewed 
recently (Archibald et al., 1993). 
 Walls of Gram-positive bacteria are dynamically variable and flexible structure 
that enclose and protect the underlying cytoplasmic membranes.  They are intimately 
involved in cell growth and morphogenesis, cell division and its environment, and 
movement of materials into and out of the cell.  During growth, the wall has to 
enlarge and change shape to accommodate the exponentially increasing volume of 
the cell and must divide to allow the formation of two daughter cells.  The forces that 
drive wall growth and the ways which growth is accomplished without compromising 
the wall’s strength is the ability to protect the protoplast (Koch and Burdett, 1986). 
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Figure 2.5 Phylogenetic trees of some members of the genus Bacillus based on 
16S rRNA sequence analysis (Ash et al., 1991).  Picture adapted from 
Vary (1994). 
